Gene discovery helps explain how flu can cause severe infections
29 June 2012
Scientists have discovered a new gene in the influenza virus that helps the virus control the body's response to infection. Although this control is exerted by the virus, surprisingly it reduces the impact of the infection. The findings will help researchers better understand how flu can cause severe infections, as well as inform research into new treatments.
Researchers found that when the virus gene - called PA-X - was active, mice infected with flu subsequently recovered. When the PA-X gene did not work properly, the immune system was found to overreact. This made the infection worse, and did not help destroy the virus any quicker.
The study looked at how the gene affected the behaviour of "Spanish flu", a virulent strain of influenza that caused a pandemic in 1918. It was carried out by the Universities of Cambridge, Cork, Edinburgh and Utah, the Institute of Systems Biology in Seattle and the United States National Institutes of Health.
The researchers, whose study is published online in the journal Science, found the hidden gene by analysing patterns of changes in the genetic information of thousands of different flu strains.
Professor Paul Digard, of The Roslin Institute at the University of Edinburgh, said: "Just finding this gene in the first place is important, but the find is even more significant because of the role it seems to play in the body's response to flu."
Dr Andrew Firth, of the University of Cambridge, said: "The flu virus has a very, very small genome - just 12 genes. Finding a new gene makes a pretty significant change to our understanding of this virus."
The research was funded by the Biotechnology and Biological Sciences Research Council, the Medical Research Council, the U. S. National Institutes of Health, Science Foundation Ireland, and the Wellcome Trust.
Tara Womersley, Press and PR Office, The University of Edinburgh
tel: 0131 650 9836
mob: 07791 355804
NIAID Office of Communications
tel: + 1-301-402-1663
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, and with an annual budget of around £445M (2011-2012), we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
Tags: press release